Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Taysha Gene Therapies (TSHA) Amortizatization of Intangibles: 2022-2025

Historic Amortizatization of Intangibles for Taysha Gene Therapies (TSHA) over the last 4 years, with Sep 2025 value amounting to $312,000.

  • Taysha Gene Therapies' Amortizatization of Intangibles rose 5.05% to $312,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 5.88%. This contributed to the annual value of $1.2 million for FY2024, which is 2.96% up from last year.
  • Taysha Gene Therapies' Amortizatization of Intangibles amounted to $312,000 in Q3 2025, which was up 1.30% from $308,000 recorded in Q2 2025.
  • Taysha Gene Therapies' Amortizatization of Intangibles' 5-year high stood at $385,000 during Q3 2022, with a 5-year trough of $274,000 in Q4 2023.
  • For the 3-year period, Taysha Gene Therapies' Amortizatization of Intangibles averaged around $305,273, with its median value being $303,000 (2023).
  • Per our database at Business Quant, Taysha Gene Therapies' Amortizatization of Intangibles decreased by 20.78% in 2023 and then grew by 9.85% in 2024.
  • Quarterly analysis of 4 years shows Taysha Gene Therapies' Amortizatization of Intangibles stood at $284,000 in 2022, then declined by 3.52% to $274,000 in 2023, then climbed by 9.85% to $301,000 in 2024, then climbed by 5.05% to $312,000 in 2025.
  • Its Amortizatization of Intangibles stands at $312,000 for Q3 2025, versus $308,000 for Q2 2025 and $339,000 for Q1 2025.